Rumours that German pharma Stada may be up for sale have been all but confirmed by the company's chief executive, who told a news agency that "exploratory talks" are taking place. Peter ...

Stada is postponing its initial public offering in Germany, the latest IPO candidate to put plans to go public on hold after U.S. President Trump’s tariff blitz rattled markets globally. The ...

Stada will postpone its planned initial public listing on the Frankfurt stock exchange as a result of U.S. tariffs, market volatility and geopolitical uncertainties. The German healthcare company ...

The European Commission has approved a biosimilar of the IL-12 and IL-23 inhibitor antibody developed by STADA and partner Alvotech – called Uzpurvo – for the treatment of plaque psoriasis ...

Putin names little known firm to run pharma company spun off from Germany's Stada Russia's president Vladimir Putin has appointed a little known company to manage assets linked to major German ...

Frankfurt (Reuters) - Der Arzneimittelhersteller Stada hält sich weiter bedeckt zu seinen konkreten Börsenplänen. "Mit unseren Eigentümern, Bain Capital und Cinven, prüfen wir grundsätzlich ...

Die Einigung kam an der Börse gut an: Stada-Aktien waren mit einem Plus von fast neun Prozent auf 88,53 Euro größter Gewinner im Nebenwerteindex MDax. "Die garantierte Dividende war eine ...